Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia.

Jessica L. Alexander, Amer N. Kalaaji, James M. Shehan, Benjamin K. Yokel, Mark R. Pittelkow

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

BACKGROUND: Urticarial vasculitis is a form of cutaneous leukocytoclastic vasculitis clinically characterized by persistent and often painful urticarial lesions. Numerous systemic diseases have been associated with urticarial vasculitis, including certain hematologic disorders. This distinctive form of cutaneous necrotizing vasculitis can be resistant to standard therapeutic modalities, necessitating more aggressive intervention. METHODS: We report a case of refractory urticarial vasculitis developing in association with B-cell chronic lymphocytic leukemia in a 46-year-old man. We also reviewed the literature to identify other cases of urticarial vasculitis managed with this therapeutic modality. RESULTS: The disease progressively improved during 6 treatments with plasmapheresis (plasma exchange). In the additional cases identified in the literature, plasmapheresis was generally effective and well tolerated. CONCLUSION: On the basis of these findings, we propose that plasmapheresis be considered a treatment option for refractory urticarial vasculitis.

Original languageEnglish (US)
Pages (from-to)534-537
Number of pages4
JournalJournal of drugs in dermatology : JDD.
Volume5
Issue number6
StatePublished - Jun 2006

Fingerprint

Plasmapheresis
B-Cell Chronic Lymphocytic Leukemia
Vasculitis
Cutaneous Leukocytoclastic Vasculitis
Plasma Exchange
Therapeutics
Skin

Cite this

Alexander, J. L., Kalaaji, A. N., Shehan, J. M., Yokel, B. K., & Pittelkow, M. R. (2006). Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia. Journal of drugs in dermatology : JDD., 5(6), 534-537.

Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia. / Alexander, Jessica L.; Kalaaji, Amer N.; Shehan, James M.; Yokel, Benjamin K.; Pittelkow, Mark R.

In: Journal of drugs in dermatology : JDD., Vol. 5, No. 6, 06.2006, p. 534-537.

Research output: Contribution to journalArticle

Alexander, JL, Kalaaji, AN, Shehan, JM, Yokel, BK & Pittelkow, MR 2006, 'Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia.', Journal of drugs in dermatology : JDD., vol. 5, no. 6, pp. 534-537.
Alexander, Jessica L. ; Kalaaji, Amer N. ; Shehan, James M. ; Yokel, Benjamin K. ; Pittelkow, Mark R. / Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia. In: Journal of drugs in dermatology : JDD. 2006 ; Vol. 5, No. 6. pp. 534-537.
@article{70db4e0476fa489ab721ab457a1cd02c,
title = "Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia.",
abstract = "BACKGROUND: Urticarial vasculitis is a form of cutaneous leukocytoclastic vasculitis clinically characterized by persistent and often painful urticarial lesions. Numerous systemic diseases have been associated with urticarial vasculitis, including certain hematologic disorders. This distinctive form of cutaneous necrotizing vasculitis can be resistant to standard therapeutic modalities, necessitating more aggressive intervention. METHODS: We report a case of refractory urticarial vasculitis developing in association with B-cell chronic lymphocytic leukemia in a 46-year-old man. We also reviewed the literature to identify other cases of urticarial vasculitis managed with this therapeutic modality. RESULTS: The disease progressively improved during 6 treatments with plasmapheresis (plasma exchange). In the additional cases identified in the literature, plasmapheresis was generally effective and well tolerated. CONCLUSION: On the basis of these findings, we propose that plasmapheresis be considered a treatment option for refractory urticarial vasculitis.",
author = "Alexander, {Jessica L.} and Kalaaji, {Amer N.} and Shehan, {James M.} and Yokel, {Benjamin K.} and Pittelkow, {Mark R.}",
year = "2006",
month = "6",
language = "English (US)",
volume = "5",
pages = "534--537",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "6",

}

TY - JOUR

T1 - Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia.

AU - Alexander, Jessica L.

AU - Kalaaji, Amer N.

AU - Shehan, James M.

AU - Yokel, Benjamin K.

AU - Pittelkow, Mark R.

PY - 2006/6

Y1 - 2006/6

N2 - BACKGROUND: Urticarial vasculitis is a form of cutaneous leukocytoclastic vasculitis clinically characterized by persistent and often painful urticarial lesions. Numerous systemic diseases have been associated with urticarial vasculitis, including certain hematologic disorders. This distinctive form of cutaneous necrotizing vasculitis can be resistant to standard therapeutic modalities, necessitating more aggressive intervention. METHODS: We report a case of refractory urticarial vasculitis developing in association with B-cell chronic lymphocytic leukemia in a 46-year-old man. We also reviewed the literature to identify other cases of urticarial vasculitis managed with this therapeutic modality. RESULTS: The disease progressively improved during 6 treatments with plasmapheresis (plasma exchange). In the additional cases identified in the literature, plasmapheresis was generally effective and well tolerated. CONCLUSION: On the basis of these findings, we propose that plasmapheresis be considered a treatment option for refractory urticarial vasculitis.

AB - BACKGROUND: Urticarial vasculitis is a form of cutaneous leukocytoclastic vasculitis clinically characterized by persistent and often painful urticarial lesions. Numerous systemic diseases have been associated with urticarial vasculitis, including certain hematologic disorders. This distinctive form of cutaneous necrotizing vasculitis can be resistant to standard therapeutic modalities, necessitating more aggressive intervention. METHODS: We report a case of refractory urticarial vasculitis developing in association with B-cell chronic lymphocytic leukemia in a 46-year-old man. We also reviewed the literature to identify other cases of urticarial vasculitis managed with this therapeutic modality. RESULTS: The disease progressively improved during 6 treatments with plasmapheresis (plasma exchange). In the additional cases identified in the literature, plasmapheresis was generally effective and well tolerated. CONCLUSION: On the basis of these findings, we propose that plasmapheresis be considered a treatment option for refractory urticarial vasculitis.

UR - http://www.scopus.com/inward/record.url?scp=33746425403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746425403&partnerID=8YFLogxK

M3 - Article

C2 - 16774105

AN - SCOPUS:33746425403

VL - 5

SP - 534

EP - 537

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 6

ER -